Document Type
Article
Publication Date
5-24-2014
Publication Title
BioMed Central Musculoskeletal Disorders
Department
Geisel School of Medicine
Abstract
As recommended in the current prescribing information, rituximab infusions in patients with rheumatoid arthritis (RA) take 4.25hours for the first infusion and 3.25hours for subsequent infusions, which is a burden on patients and the health care system. We therefore evaluated the safety of infusing rituximab at a faster rate for an infusion period of 2hours in patients with RA.
DOI
10.1186/1471-2474-15-177
Dartmouth Digital Commons Citation
Pritchard, Charles H.; Greenwald, Maria W.; Kremer, Joel M.; Gaylis, Norman B.; and Rigby, William, "Safety of Infusing Rituximab at a More Rapid Rate in Patients with Rheumatoid Arthritis: Results from the RATE-RA Study" (2014). Dartmouth Scholarship. 654.
https://digitalcommons.dartmouth.edu/facoa/654
Included in
Musculoskeletal Diseases Commons, Rehabilitation and Therapy Commons, Rheumatology Commons